5576 - 5600 of 9140 Results
Title
Year
- Carrying on a Father's Legacy2025RESTRICTEDTitle: Carrying on a Father's LegacyJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 4Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0001125860.72537.e7Citation Count: 0
- Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results2025RESTRICTEDTitle: Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial resultsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 134Issue #:Start Page: 107560End Page: 107560Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107560Citation Count: 0
- Exploring MAPT-containing H1 and H2 haplotypes in Parkinson’s disease across diverse populations2026OPENTitle: Exploring MAPT-containing H1 and H2 haplotypes in Parkinson’s disease across diverse populationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01394-9Best OA location URL: https://www.nature.com/articles/s41531-026-01394-9_reference.pdfCitation Count: 0
-
OPENTitle: Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational StudyJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 14Issue #:Start Page: e71955End Page: e71955Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/71955Best OA location URL: https://doi.org/10.2196/71955Citation Count: 0
-
OPENTitle: Collaborative action for biomarker breakthroughs: Validating α-synuclein seed amplification assays in Parkinson's diseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261431949End Page: 1877718X261431949Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261431949Best OA location URL: https://doi.org/10.1177/1877718x261431949Citation Count: 0
-
OPENTitle: Insights and priorities from the 2025 private funders’ Parkinson's disease and related disorders large footprint data interoperability summitJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261430266End Page: 1877718X261430266Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261430266Best OA location URL: https://doi.org/10.1177/1877718x261430266Citation Count: 0
- Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Partnering With Participant Advisors on the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78220Citation Count: 0
- The Parkinson's Progression Markers Initiative: Why Then? Why Now?2026RESTRICTEDTitle: The Parkinson's Progression Markers Initiative: Why Then? Why Now?Journal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78192Citation Count: 0
- Return of Individual Research Information in the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Return of Individual Research Information in the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78228Citation Count: 0
- From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI2026RESTRICTEDTitle: From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78242Citation Count: 0
-
OPENTitle: Practical approaches to inclusive recruitment practices in Parkinson's disease researchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 709End Page: 722Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261440708Best OA location URL: https://doi.org/10.1177/1877718x261440708Citation Count: 0
- Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI2026RESTRICTEDTitle: Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78230Citation Count: 0
- Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI2026RESTRICTEDTitle: Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78245Citation Count: 0
- Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78249Citation Count: 0
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
-
OPENTitle: Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone ratsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 346Issue #:Start Page: 137End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5860948Citation Count: 4
-
OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 17
-
OPENTitle: Shortening the SWAL-QOL: Is it possible to create a valid short form?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 148Issue #:Start Page: 108362End Page: 108362Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108362Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13225615/Citation Count: 0
- Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease2016RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 83
-
OPENTitle: Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screeningJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 47Start Page: 12746End Page: 12754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d0sc02159hBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2020/sc/d0sc02159hCitation Count: 58
-
OPENTitle: Cerebellar contributions to cognitive deterioration in Parkinson's disease: Insights from multi-omics and longitudinal dataJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 219Issue #:Start Page: 107275End Page: 107275Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2026.107275Best OA location URL: https://doi.org/10.1016/j.nbd.2026.107275Citation Count: 0
- Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging2022OPENTitle: Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR ImagingJournal Name: American Journal of NeuroradiologyPublisher: American Society of Neuroradiology (ASNR)Vol: 43Issue #: 3Start Page: 354End Page: 360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3174/ajnr.a7410Best OA location URL: https://www.ajnr.org/content/ajnr/43/3/354.full.pdfCitation Count: 7
- Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease2016RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 43
-
OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 1
- Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspective2025RESTRICTEDTitle: Diverse paths of phenotypic evolution in functional movement disorders: A longitudinal perspectiveJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 144Issue #:Start Page: 108059End Page: 108059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108059Citation Count: 1